Correction: Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2022-10-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/10/e029101corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
by: Ben W Mol, et al.
Published: (2019-11-01) -
Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up
by: Martijn A Oudijk, et al.
Published: (2024-07-01) -
The effectiveness and safety of continuous and repeated treatment of atosiban in twin pregnancy with threatened preterm labor: A propensity score-matched study.
by: Hao Zhu, et al.
Published: (2025-01-01) -
The effectiveness and safety of continuous and repeated treatment of atosiban in twin pregnancy with threatened preterm labor: A propensity score-matched study
by: Hao Zhu, et al.
Published: (2025-01-01) -
The Effect of Probiotics on Preterm Birth Rates in Pregnant Women After a Threatened Preterm Birth Episode (The PROPEV Trial)
by: Ester del Barco, et al.
Published: (2025-05-01)